EXACT Sciences Aktie
WKN: 590273 / ISIN: US30063P1057
08.01.2024 03:39:32
|
Exact Sciences Sees Q4 Revenue Above View; CFO Jeff Elliott To Step Down
(RTTNews) - Exact Sciences Corp. (EXAS) expects total revenue for fourth quarter to be in the range of $645.5 million-$647.5 million, an increase of 17% compared to the fourth quarter of 2022. Analysts polled by Thomson Reuters expect the company to report revenues of $631.52 million for the fourth quarter. Analysts' estimates typically exclude special items.
The company expects total full-year 2023 revenue of $2.50 billion and 2024 revenue of $2.83 billion. Analysts expect revenue of $2.48 billion for fiscal year 2023 and $2.83 billion for fiscal year 2024.
The company also announced that Jeff Elliott plans to step down as Executive Vice President and Chief Financial Officer in 2024 due to personal reasons. Elliott will continue in his role as CFO until a successor is appointed.
The company has engaged a nationally recognized executive search firm to review both internal and external candidates for its next Chief Financial Officer.
Exact Sciences plans to report 2023 financial results during its February 2024 earnings call.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu EXACT Sciences Corp.mehr Nachrichten
Analysen zu EXACT Sciences Corp.mehr Analysen
Aktien in diesem Artikel
EXACT Sciences Corp. | 45,27 | 2,40% |
|